SPON2 and lung adenocarcinoma: demonstrated that SPON2 augmented migration, invasion, and EMT of lung adenocarcinoma (LUAD) cells in vitro, while silencing SPON2 significantly impeded LUAD cell-mediated bone metastasis in vivo.